Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Theophylline vs Sumatriptan for PDPH
NCT04257851Phase 4Completed
- Sponsor
- Damanhour Teaching Hospital
- Start
- Feb 2020
- Primary completion
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of theophylline in post-dural puncture headache (PDPH) (2 arms), sponsored by Damanhour Teaching Hospital. Primary endpoint: Numeric Pain Rating Scale Score at 48 hours. Started Feb 2020; status: completed.
02
Drugs
theophylline
03
Conditions
post-dural puncture headache (PDPH)
Beyond the preview
Go deeper on NCT04257851.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04257851.